Owens & Minor, Inc. (NYSE:OMI) Director Gwendolyn M. Bingham Sells 7,600 Shares of Stock

Owens & Minor, Inc. (NYSE:OMIGet Rating) Director Gwendolyn M. Bingham sold 7,600 shares of Owens & Minor stock in a transaction that occurred on Thursday, May 12th. The stock was sold at an average price of $35.32, for a total transaction of $268,432.00. Following the sale, the director now owns 22,184 shares of the company’s stock, valued at approximately $783,538.88. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.

Shares of OMI opened at $36.05 on Friday. The company has a debt-to-equity ratio of 2.78, a quick ratio of 0.67 and a current ratio of 1.54. Owens & Minor, Inc. has a twelve month low of $29.85 and a twelve month high of $49.16. The firm’s 50 day moving average price is $41.16 and its two-hundred day moving average price is $41.79. The firm has a market cap of $2.74 billion, a P/E ratio of 14.31, a PEG ratio of 1.27 and a beta of 0.46.

Owens & Minor (NYSE:OMIGet Rating) last announced its quarterly earnings results on Tuesday, May 3rd. The company reported $0.96 earnings per share for the quarter, beating analysts’ consensus estimates of $0.77 by $0.19. Owens & Minor had a net margin of 1.94% and a return on equity of 29.89%. The firm had revenue of $2.41 billion for the quarter, compared to analyst estimates of $2.31 billion. During the same quarter in the previous year, the firm posted $1.57 earnings per share. The business’s revenue was up 3.5% on a year-over-year basis. On average, sell-side analysts anticipate that Owens & Minor, Inc. will post 3.35 earnings per share for the current fiscal year.

Several brokerages have recently commented on OMI. Zacks Investment Research cut shares of Owens & Minor from a “buy” rating to a “hold” rating in a research report on Friday, May 6th. Citigroup began coverage on shares of Owens & Minor in a report on Tuesday, April 26th. They set a “buy” rating for the company. StockNews.com cut shares of Owens & Minor from a “buy” rating to a “hold” rating in a report on Wednesday. Finally, Credit Suisse Group boosted their price objective on shares of Owens & Minor from $42.00 to $43.00 and gave the company a “neutral” rating in a report on Monday, February 28th. Four equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $49.80.

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Verition Fund Management LLC bought a new stake in shares of Owens & Minor in the first quarter worth $303,000. Charles Schwab Investment Management Inc. lifted its position in shares of Owens & Minor by 0.6% in the first quarter. Charles Schwab Investment Management Inc. now owns 872,427 shares of the company’s stock worth $38,404,000 after purchasing an additional 4,958 shares in the last quarter. First Trust Advisors LP lifted its position in shares of Owens & Minor by 239.0% in the first quarter. First Trust Advisors LP now owns 116,442 shares of the company’s stock worth $5,126,000 after purchasing an additional 82,091 shares in the last quarter. Baird Financial Group Inc. lifted its position in shares of Owens & Minor by 3.5% in the first quarter. Baird Financial Group Inc. now owns 14,784 shares of the company’s stock worth $650,000 after purchasing an additional 503 shares in the last quarter. Finally, Vanguard Group Inc. lifted its position in shares of Owens & Minor by 0.8% in the first quarter. Vanguard Group Inc. now owns 8,068,497 shares of the company’s stock worth $355,176,000 after purchasing an additional 61,721 shares in the last quarter. 95.69% of the stock is currently owned by hedge funds and other institutional investors.

Owens & Minor Company Profile (Get Rating)

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers.

Read More

Insider Buying and Selling by Quarter for Owens & Minor (NYSE:OMI)

Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.